Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2020

Jul 31, 2020

30870_dirs_2020-07-30_3c6fee97-2db7-49c3-843b-509c4290f2c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-07-29

Reporting Person: SCHLOSSBERG MARK A (SVP - Legal & General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-29 Common Stock M 10000 $7.03 Acquired 40000 Direct
2020-07-29 Common Stock S 10000 $23.0728 Disposed 30000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-29 Non-Qualified Stock Option (right to buy) $7.03 M 10000 Disposed 2029-01-31 Common Stock (10000) Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020.